Catheter Precision, Inc. has secured up to $36.5 million in strategic institutional financing to support accelerated growth. As part of this transaction, the company has agreed to terminate its at-the-market (ATM) equity offering program, with no future equity lines of credit or forward-priced agreements anticipated. In addition, Catheter Precision has strengthened its balance sheet by converting short-term notes into long-term obligations, extending maturities to two and three years, and converting approximately $9 million of additional short- and long-term liabilities into equity. This restructuring is designed to provide the company with financial flexibility to advance growth initiatives, scale business opportunities, and expand its market presence.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Catheter Precision Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9653452) on February 12, 2026, and is solely responsible for the information contained therein.